CN118613267A - 水性液体制剂 - Google Patents

水性液体制剂 Download PDF

Info

Publication number
CN118613267A
CN118613267A CN202380018185.6A CN202380018185A CN118613267A CN 118613267 A CN118613267 A CN 118613267A CN 202380018185 A CN202380018185 A CN 202380018185A CN 118613267 A CN118613267 A CN 118613267A
Authority
CN
China
Prior art keywords
aqueous liquid
arbekacin
water
soluble polymer
liquid preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380018185.6A
Other languages
English (en)
Chinese (zh)
Inventor
西田梦央
中村祐辉
坂井达也
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju USA Inc
Original Assignee
Senju USA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju USA Inc filed Critical Senju USA Inc
Publication of CN118613267A publication Critical patent/CN118613267A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
CN202380018185.6A 2022-01-21 2023-01-20 水性液体制剂 Pending CN118613267A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022-007774 2022-01-21
JP2022007774 2022-01-21
PCT/JP2023/001725 WO2023140357A1 (ja) 2022-01-21 2023-01-20 水性液剤

Publications (1)

Publication Number Publication Date
CN118613267A true CN118613267A (zh) 2024-09-06

Family

ID=87348335

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380018185.6A Pending CN118613267A (zh) 2022-01-21 2023-01-20 水性液体制剂

Country Status (8)

Country Link
US (2) US12296015B2 (https=)
EP (1) EP4467144A4 (https=)
JP (2) JP7479744B2 (https=)
KR (1) KR20240134913A (https=)
CN (1) CN118613267A (https=)
CA (1) CA3244189A1 (https=)
MX (1) MX2024009025A (https=)
WO (1) WO2023140357A1 (https=)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5651499A (en) 1979-10-01 1981-05-09 Meiji Seika Kaisha Ltd Aminoglycoside derivative and its preparation
JPS58134099A (ja) 1982-02-05 1983-08-10 Meiji Seika Kaisha Ltd アミノ配糖体抗生物質の精製法
JP2002097129A (ja) * 2000-07-21 2002-04-02 Rohto Pharmaceut Co Ltd 点眼剤
EP1683526B1 (en) * 2003-11-14 2012-04-11 Senju Pharmaceutical Co., Ltd. Aqueous solution preparation containing aminoglycoside antibiotic and bromfenac
JP4736540B2 (ja) * 2004-05-27 2011-07-27 参天製薬株式会社 眼科用粘稠化剤
ES2510667T3 (es) 2004-05-27 2014-10-21 Santen Pharmaceutical Co., Ltd Colirio
US8748402B2 (en) * 2004-06-07 2014-06-10 Bausch & Lomb Pharma Holdings Corp. Ophthalmic formulations and uses thereof
CN105944105A (zh) 2008-06-12 2016-09-21 前瞻生物治疗公司 一种眼科组合物中的防腐剂替代物聚维酮碘
WO2010141831A1 (en) * 2009-06-05 2010-12-09 Aciex Therapeutics, Inc. Ophthalmic formulations, methods of manufacture, and methods of using same
US8211450B2 (en) * 2010-05-05 2012-07-03 Senju Usa, Inc. Ophthalmic composition
ES2532667T3 (es) 2011-09-12 2015-03-30 Meiji Seika Pharma Co., Ltd. Composiciones acuosas que contienen arbekacina
JP2018522070A (ja) 2015-07-27 2018-08-09 キャタコア・インコーポレイテッドＣａｔａｃｏｒｅ， Ｉｎｃ． 白内障の処置用組成物
CN106474149A (zh) * 2016-12-23 2017-03-08 常州润诺生物科技有限公司 一种复方氨基糖苷类抗生素的口服制剂及其制备方法与应用
CN106420811A (zh) * 2016-12-23 2017-02-22 常州润诺生物科技有限公司 一种氨基糖苷类抗生素的口服制剂及其制备方法与应用

Also Published As

Publication number Publication date
CA3244189A1 (en) 2025-06-13
US12296015B2 (en) 2025-05-13
JPWO2023140357A1 (https=) 2023-07-27
JP2024096898A (ja) 2024-07-17
MX2024009025A (es) 2024-08-06
EP4467144A1 (en) 2024-11-27
WO2023140357A1 (ja) 2023-07-27
US20250235541A1 (en) 2025-07-24
EP4467144A4 (en) 2026-01-21
KR20240134913A (ko) 2024-09-10
JP7479744B2 (ja) 2024-05-09
US20240307544A1 (en) 2024-09-19

Similar Documents

Publication Publication Date Title
US12168017B2 (en) D2O stabilized pharmaceutical formulations
CN110461350B (zh) 稳定的肽组合物
US20240139166A1 (en) Ophthalmic compositions for presbyopia
JP2018203791A (ja) 眼科用アレルギー予防剤
EA034839B1 (ru) Офтальмологический раствор
CN107708416B (zh) 肽组合物和使用方法
TW201701882A (zh) 含有糖皮質類固醇（ｇｌｕｃｏｃｏｒｔｉｃｏｉｄｓ）之奈米微粒子之水性懸浮液劑
JP2026067867A (ja) Ｄ２ｏを含む眼科用組成物
Al-Bazzaz et al. Ophthalmic in-situ sustained gel of ciprofloxacin, preparation and evaluation study
EP4461364B1 (en) Laquinimod formulation for ocular use
JP7828519B2 (ja) 高分子量ヒアルロン酸の眼科用薬物輸送ビヒクルとしての使用
JP2010204597A (ja) ソフトコンタクトレンズ用組成物及びソフトコンタクトレンズへの吸着抑制方法
CN118613267A (zh) 水性液体制剂
JP6503085B2 (ja) ドライアイ疾患を治療及び／又は予防するための短い合成ペプチドの使用
RU2842860C1 (ru) Водная суспензионная композиция, содержащая сиролимус или его соль
HK40102218B (en) Laquinimod formulation for ocular use
TWI540141B (zh) 短合成胜肽及其治療和／或預防乾眼症之用途
EA051540B1 (ru) Композиция лаквинимода для глазного применения
TW201100071A (en) Ophthalmic composition and vitamin A stabilization method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination